Concepedia

D. P. Cohen

DP

Statistics

Publications

3

Citations

1.2K

H-Index

3

Active since

2009

Affiliations

Pfizer (United States)(Current)

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

D. P. Cohen is an author at Pfizer (United States) specializing in cancer therapeutics, radiation oncology, and surgical oncology.

Top concepts

Publications per year

2009–2014

3

Publications

3

Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Brian I. Rini, D. P. Cohen, Dongrui R. Lu et al. · JNCI Journal of the National Cancer Institute · 2011 · 575 citations · Full text

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

Suzanne George, Jean‐Yves Blay, Paolo G. Casali et al. · European Journal of Cancer · 2009 · 365 citations

, , +9

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

S.-H.I. Ou, Pasi A. Jänne, Cynthia Huang Bartlett et al. · Annals of Oncology · 2014 · 220 citations · Full text

1–3 of 3